Grifols Dividend yield




A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
   EUR per share 
 Price  25.19
 Dividend  0.20
 Earnings  1.06
 Cash-flow  1.23
 Book value  5.36
 Equity  5.35

Grifols is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Grifols is a company from Spain, and his stocks are publicly traded.

Grifols paid a total dividend of 85 million EUR last year, for a market value of 10,731 millions (Market Cap 8,325 millions). Dividend per share of Grifols is 0.20 EUR, and his stock market price 25.19 EUR.

According to the chart below, where dividend yield is displayed, Grifols has a dividend yield of 0.81%, lower than the amount offered by both the market average and companies from Spain. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...

In addition, you should compare Grifols dividend yield with other Pharmaceuticals and Biotechnology companies or firms from Spain.

Dividend yield of Grifols

Grifols Dividend Payout

About the ability of Grifols to maintain his current dividend of EUR 0.20 per share, an amount that accounts for 0.81%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Grifols payout on ernings is currently 18.87%, which is lower than the market average and companies of Health Care industry, which are 39.89% and 26.06% respectively. Both figures lead us to believe that there is confidence that Grifolscan maintain his current dividend.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Grifols is EUR 1.23 per share, which is higher than the dividend per share paid by the company of EUR 0.20, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Grifols, compared againt world market average, Spain companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Grifols payout

Grifols Stock performance

Finally, last moth Grifols showed a return of 3.80% compared to a worldwide -7.28% average, and a -8.04% of Health Care firms. Over the last year, the company obtained a -6.30% versus a worldwide performance of a -4.98%. More detailed information can be seen in the following graph for Spain and Pharmaceuticals and Biotechnology firms.

Grifols stock and market return

Next companies

Grindrod. South Africa. Industrials.

Grindrod Shipping Holdings. South Africa. Industrials.

Group 3i. UK. Financials.

Groupe Bruxelles Lam. Belgium and Lux.. Financials.

Groupe Eurotunnel. France. Industrials.

Growthpoint Prop Ltd. South Africa. Financials.

Previous companies

Grenke AG. Germany. Financials.

Grendene SA. Brazil. Consumer Goods.

Greentown China Hold. China. Financials.

Gree. Japan. Consumer Services.

Great-West Lifeco. Canada. Financials.

Great Wall Motor Com. China. Consumer Goods.

 

 

All rights reserved

 information advertisement legal

Dividends Ranking | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.